Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin Dose on Myocardial Repolarization in C-Section
NCT03716076Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Nov 2018
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by University of British Columbia. Primary endpoint: Transmural dispersion of repolarization (Tp-e interval). Started Nov 2018; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03716076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716076.